$GBLX Mon, 02 Jun 2014 20:28:00 GMT ~ GrowBLOX Sc
Post# of 74540
[PR Newswire] - LAS VEGAS, June 2, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (GBLX), a biotechnology and research company, announced today that the company has raised $5 million through a private placement of its common stock. Shares were sold to accredited and institutional investors, and proceeds will be used to support GrowBLOX Sciences' continued growth, as well as for general corporate purposes. "We are very pleased with the success of this capital raise and the expression of continued confidence from the investment community," said Steven Weldon, Director and CFO of GrowBLOX Sciences, Inc., "the additional capital will allow us to continue business plans for the manufacturing of our GrowBLOX indoor growing chambers and the continued pursuit of medical marijuana licenses across the United States." As of June 2, 2014, GrowBLOX Sciences, Inc. has 21,415,655 shares outstanding. GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
read full: http://finance.yahoo.com/news/growblox-scienc...00915.html